Women included between 18 and 45 years old, pregnant during their second or third trimester of pregnancy (calculated by a sure menstrual date and confirmed by a 1st trimesteric ultrasound) with hemoglobin level below 10.5 mg /dL.
All patients in the study were subjected to: 1. Detailed history was recorded. A proper history concerning age, sex, residence, socioeconomic status, onset, progression, and previous treatment of anemia was taken. Participants' socio-demographic characteristics including gravida and parity were documented, level of education, occupation, Diet, and information useful to determine the socioeconomic level was recorded. Information on previous pregnancies and children and history of chronic diseases were also recorded. 2. General examination; patients were clinically examined and gestational age (assessed by measuring the fundal height), weight was calculated for each participant. 3. Diagnosis of anemia by Complete blood count (CBC), Hb level and measuring hematocrit concentration. 4. Diagnosis of parasitic infection by stool analysis using suitable techniques. 5. Imaging including obstetric ultrasound (U/S) to assess fetal development. 6. Women with helminthic infections will be divided into groups Group (A): received iron + antiparasitic treatment as follows: * Patients who have STH received alzental 200mg tab 2 tabs single oral dose. * Patients who have Entamoeba or Giardia received flagyl 500mg tab twice daily for 5 days. * (B): received iron only.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
oral tablet twice daily after meals
500 mg oral twice daily
200 mg oral single dose
Kasr Alainy medical school
Cairo, Egypt
RECRUITINGcorrection of naemia
hemoglobin level increased above 11 gm/dL
Time frame: 6 weeks after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.